U.S. markets open in 1 hour 29 minutes

Idera Pharmaceuticals, Inc. (IDRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6900+0.1300 (+5.08%)
At close: 4:00PM EDT

2.7185 +0.03 (1.06%)
Before hours: 8:00AM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/23/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
74.97M61.38M40.40M54.00M83.40M
Enterprise Value 3
44.95M27.89M-2.39M12.56M31.22M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
42.0936.9426.0233.0047.19
Price/Book (mrq)
1.24N/AN/A1.441.75
Enterprise Value/Revenue 3
25.28N/AN/AN/AN/A
Enterprise Value/EBITDA 6
-0.82-3.490.18-0.54-2.81

Trading Information

Stock Price History

Beta (5Y Monthly) 2.08
52-Week Change 31.89%
S&P500 52-Week Change 37.69%
52 Week High 32.9500
52 Week Low 30.8100
50-Day Moving Average 32.2711
200-Day Moving Average 32.0335

Share Statistics

Avg Vol (3 month) 3210.58k
Avg Vol (10 day) 3201.85k
Shares Outstanding 535.2M
Float 26.37M
% Held by Insiders 118.24%
% Held by Institutions 127.53%
Shares Short (Oct 14, 2020) 4461.61k
Short Ratio (Oct 14, 2020) 42.67
Short % of Float (Oct 14, 2020) 41.70%
Short % of Shares Outstanding (Oct 14, 2020) 41.31%
Shares Short (prior month Sep 14, 2020) 4475.77k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Jul 29, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-62.18%
Return on Equity (ttm)-331.34%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-24.09M
EBITDA -44.24M
Net Income Avi to Common (ttm)-77.82M
Diluted EPS (ttm)-2.6270
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)31.01M
Total Cash Per Share (mrq)0.88
Total Debt (mrq)981k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.47
Book Value Per Share (mrq)-0.52

Cash Flow Statement

Operating Cash Flow (ttm)-40.27M
Levered Free Cash Flow (ttm)-24.15M